Source: Guangdong Tencent News
TAEST16001 of Xiangxue has been the first TCR-T IND (Investigational New Drug) in China approved by NMPA (National Medical Products Administration).
With independent intellectual property rights, Xiangxue Life Scie...
Source: Science and Technology Daily （http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2019-03/08/content_416582.htm?div=-1）
Subject：Science and Technology Daily（special sections for NPC&CPPCC）- Xiangxue, Embracing Change
Subject：National Key R&D Project – “Development and Industrialization of Hua Juhong （Genuine Herb）
The project focuses on bottleneck of industrial development. In the next three years, the project is aimed to build the whole industrial chain for Hua J...
No. 2, Jinfengyuan Road, Science City,
Guangzhou Economic and Technological Development Zone